800-872-2273

Clinical Trials and Studies

Study Title	Principal Investigator
A Phase 2, Multicenter, Open-label Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Subjects With HER2+ AR+ Metastatic or Locally Advanced Breast Cancer Not recruiting \| Breast Cancer \| Multisite View full trial information >>	Executive Director
<< < 57 58 59 60 61 ... 63 >>